Dr. Ray Urbanski is a strong believer in cannabinoids.
Cannabinoids are useful agents for the treatment of a whole range of ailments and diseases.
This is the ideal time and environment to make these products and drugs available.
Will establish organizational structure, processes and key hires necessary to continue the growth of Applied BioSciences.
Overseeing the development of key products in the Applied BioSciences’ product pipeline
Directing development within the newly formed Applied BioPharma Division which is focused on innovative cannabinoid therapies being developed to address the unmet medical needs of patients across multiple therapeutic areas.
About Applied BioSciences Corp. Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.
About Trace Analytics Inc. Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology. The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com